Fig. 5.
Chromatin remodeling across 5q35.2 after drug treatment in the HCT116 cell line. The active histone modifications AcH3K9, AcH4K16, H3K4me3, and the inactive histone modification H3K27me3 in the drug-treated cells are shown as relative to the levels of the untreated cell line. Light gray bars correspond to the 5-AzaC treatment, and black bars correspond to the 5-AzaC/TSA treatment.